Multitude Therapeutics Inc.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS2
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| AMT-253 for injection NCT06209580 |
P1/2 | Recruiting | Malignant Melanoma; Advanced Solid Tumors | 96 | 2026-04-30 (+12 mo) |
| AMT-116 NCT06782334 |
P1/2 | Recruiting | Advanced Solid Tumors | 144 | 2026-06-30 |
| AMT-116 NCT07590531 |
P1/2 | Recruiting | Advanced Non-small Cell Lung Cancer (NSCLC) | 118 | 2027-05-30 |
| AMT-676 NCT07474727 |
P2 | Recruiting | Colorectal Cancer | 180 | 2027-09-30 |
| AMT-116 NCT07718737 |
P2/3 | Recruiting | NSCLC (Advanced Non-small Cell Lung Cancer) | 512 | 2028-03-30 |